Safety of Weekly Single versus Divided Administration of Moderate-dose Erythropoietin in the Treatment of Maintenance Hemodialysis Patients with Renal Anemia

Background From previous studies, the frequency of administration of recombinant human erythropoietin injection (rHuEPO) has no association with its therapeutic effect in renal anemia in chronic kidney disease (CKD), and there is no significant difference in the efficacy between weekly single dosing...

Full description

Bibliographic Details

Published in:	Zhongguo quanke yixue
Main Author:	WU Xiuling, LI Jianjun, YU Ying, XING Rong, WANG Lu, WANG Xuedong, TENG Fubin
Format:	Article
Language:	Chinese
Published:	Chinese General Practice Publishing House Co., Ltd 2023-02-01
Subjects:	renali insufficiency, chronic|renal dialysis|erythropoietin|renal anemia|administration frequency|equivalence trial
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220647.pdf